Loading clinical trials...
Loading clinical trials...
This study will evaluate the benefits and side effects of a new medication called Cinacalcet for treating patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT04292288 · Hypercalcemia, Granuloma
NCT05585593 · Comorbidities and Coexisting Conditions, Morality, and more
NCT00415584 · Secondary Hyperparathyroidism, Hypercalcemia
NCT04299425 · Parathyroid Adenoma, Parathyroid Neoplasms, and more
NCT00581828 · Osteoporosis, Osteopenia, and more
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions